CD44s Expression is Associated with Improved Survival in Soft Tissue Sarcoma

Anticancer Research

Volumn 24, Issue 2 C, 2004, Pages 1053-1056

  Peiper, Matthias ^a,c   Sato, Takeo ^a   Zurakowski, David ^b   Eisenberger, Claus ^a,c   Heinecke, Antje ^a   Hosch, Stefan ^a,c   Knoefel, Wolfram Trudo ^a,c  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

CD44s; Soft tissue sarcoma; Survival; Tumor prognosis

Indexed keywords

HERMES ANTIGEN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECURRENT DISEASE; SOFT TISSUE SARCOMA;

ADULT; AGED; ANTIGENS, CD44; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; SOFT TISSUE NEOPLASMS; SURVIVAL RATE;

EID: 2442478679     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Peiper M, Zurakowski D and Zornig C: Survival in primary soft tissue sarcoma of the extremities and trunk. Langenbecks Arch Chir 382: 203-208, 1997.
2. Peiper M, Zurakowski D, Schwarz R, Weh HJ and Zornig C: Survival in patients with primary soft-tissue sarcomas treated within 6 years. J Cancer Res Clin Oncol 124: 199-206; 1998.
3. Kaplan EL and Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 58: 457-481, 1958.
4. Cox DR. Regression models and life-tables (with discussion). J Royal Stat Soc, Series B 34: 187-220, 1972.
5. Li Y and Heldin P: Hyaluronan production increases the malignant properties of mesothelioma cells. Br J Cancer 85: 600-607, 2001.
6. Forsberg UH, Ala-Kapee MM, Jalkanen S, Andersson LC and Schroder J: The gene for human lymphocyte homing receptor is located on chromosome 11. Eur J Immunol 19: 409-412, 1989.
7. Humphrey G, Hazel DL, MacLennan K and Lewis IL: Expression of CD44 by rhabdomyosarcoma: a new prognostic marker? Br J Cancer 80: 918-921, 1999.
8. Terpe HJ, Christiansen H, Gonzalez M, Berthold F and Lampert F: Differentiation and prognosis of neuroblastoma in correlation to the expression of CD44s. Eur J Cancer 31A: 549-552, 1995.
9. Nguyen VN, Mirejovsky T, Melinova L and Mandys V: CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance. Neoplasma 47: 400-408, 2000.
10. Gotoda T, Matsumura Y, Kondo H, Ono H, Kanamoto A, Kato H, Watanabe H, Tachimori Y, Nakanishi Y and Kakizoe T: Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma. Gut 46: 14-19, 2000.
11. Kuryu M, Ozaki T, Nishida K, Shibahara M, Kawai A and Inoue H: Expression of CD44 variants in osteosarcoma. J Cancer Res Clin Oncol 125: 646-652, 1999.
12. Yoo CH, Noh SH, Kim H, Lee HY and Min JS: Prognostic significance of CD44 and nm23 expression in patients with stage II and stage HIA gastric carcinoma. J Surg Oncol 71: 22-28, 1999.
13. Kahara N, Ozaki T, Doi T, Nishida K, Kawai A, Shibahara M and Inoue H: CD44 expression in soft tissue sarcomas. Virchows Arch 436: 574-578, 2000.
14. Maula S, Huuhtanen RL, Blomqvist CP, Wiklund TA, Laurila P and Ristamaki R: The adhesion molecule CD44v6 is associated with a high risk for local recurrence in adult soft tissue sarcomas. Br J Cancer 84: 244-252, 2001.
15. Hashii K, Tohya K, Kimura M, Tateyama I, Mori T, Kadota E, Hashimoto S and Tomura T: Novel animal model of lymph node metastasis by intrauterine inoculation of the actively metastatic subline PL3 separated from rat Walker 256 tumor cells. Invasion Metastasis 17: 149-157; 1997.
16. Washington K, Gottfried MR and Telen MJ: Expression of the cell adhesion molecule CD44 in gastric adenocarcinomas. Hum Patho 25: 1043-1049, 1994.